[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100560154":3},{"organization":4,"armGroups":7,"interventions":38,"overallOfficials":10,"centralContacts":43,"locations":49,"responsibleParty":67,"collaborators":10,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":10,"eligibilityCriteria":75,"healthyVolunteers":76,"sex":77,"minAge":78,"maxAge":79,"enrollmentInfo":80,"targetDuration":83,"studyType":84,"phases":10,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":52,"whyStopped":10,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Henan University of Traditional Chinese Medicine","OTHER",[8,14,17,20,23,26,29,32,35],{"label":9,"type":10,"description":11,"interventionNames":12},"acute exacerbation CARAS",null,"Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.",[13],"Other: questionnaire survey",{"label":15,"type":10,"description":11,"interventionNames":16},"chronic persistence CARAS",[13],{"label":18,"type":10,"description":11,"interventionNames":19},"clinical control CARAS",[13],{"label":21,"type":10,"description":11,"interventionNames":22},"acute exacerbation BA",[13],{"label":24,"type":10,"description":11,"interventionNames":25},"chronic persistence BA",[13],{"label":27,"type":10,"description":11,"interventionNames":28},"clinical control BA",[13],{"label":30,"type":10,"description":11,"interventionNames":31},"intermittent AR",[13],{"label":33,"type":10,"description":11,"interventionNames":34},"persistent AR",[13],{"label":36,"type":10,"description":11,"interventionNames":37},"healthy individuals",[13],[39],{"type":6,"name":40,"description":41,"armGroupLabels":42,"otherNames":10},"questionnaire survey","subjects fill out questionnaires",[21,9,24,15,27,18,36,30,33],[44],{"name":45,"role":46,"phone":47,"phoneExt":10,"email":48},"Yang Xie","CONTACT","13526621325","xieyanghn@163.com",[50],{"facility":51,"status":52,"city":53,"state":54,"zip":10,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"The First Affiliated Hospital of Henan University of Chinese Medicine","RECRUITING","Henan","Zhengzhou","China","CN",{"type":58,"coordinates":59},"Point",[60,61],112.22494,37.92189,{"lat":61,"lon":60},[64],{"name":65,"role":46,"phone":66,"phoneExt":10,"email":48},"Yang Xie, Ph.D","+8613526621325",{"type":68,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100560154","exhaled-breath-condensate-biomarkers-in-caras-100560154",false,"NCT06573450","Exhaled Breath Condensate Biomarkers in CARAS","Preliminary Application and Evaluation of Exhaled Breath Condensate Biomarkers in Combined Allergic Rhinitis and Asthma Syndrome (CARAS)","Inclusion Criteria:\n\n* Patients with AR, BA and CARAS who meet the Western medical diagnostic criteria;\n* Chinese medical evidence consistent with lung qi deficiency evidence, phlegm-heat congestion of the lung evidence, or wind-heat offending the lung evidence;\n* Age 18 to 80 years;\n* Voluntarily accepted the study and signed an informed consent form;\n* Not participated in other clinical studies within 1 month before enrollment.\n\nExclusion Criteria:\n\n* Patients with combined vasomotor rhinitis and eosinophilic non-allergic rhinitis, other non-allergic rhinitis diseases that can cause symptoms such as nasal congestion and runny nose;\n* Patients who are participating in other drug trials;\n* Patients with a combination of other serious systemic diseases;\n* Pregnant or lactating women;\n* Patients with confusion, disorders of consciousness, dementia, and various psychiatric disorders.",true,"ALL","18 Years","80 Years",{"count":81,"type":82},270,"ESTIMATED","1 Day","OBSERVATIONAL","To explore the differences in the expression of biomarkers in different sample types between the healthy population and different subgroups of the disease, and to screen for potential biomarkers in a more simple, direct and objective way. To screen the biomarkers that can be identified by CARAS Chinese medicine symptoms and different stages, and to provide a reference basis for individualised diagnosis and treatment of the disease.",[87],"Combined Allergic Rhinitis and Asthma Syndrome",[89,90,91,92],"CARAS","EBC","Biomarkers","Combination of disease and evidence","2024-08-27",{"date":95,"type":96},"2024-08-28","ACTUAL",{"date":98,"type":96},"2023-04-01",{"date":100,"type":82},"2025-05-30",{"name":5,"class":6},1]